Corundum Group, Inc. Amgen Inc Transaction History

Corundum Group, Inc.

$254 Million
Q2 2024

A detailed history of Corundum Group, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Corundum Group, Inc. holds 4,113 shares of AMGN stock, worth $1.31 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

4,113

Previous 1,947 111.25%

Holding current value

$1.31 Million

Previous $553,000 132.37%

% of portfolio

0.51%

Previous 0.27%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	BUY	$262.75 - $319.31 $569,116 - $691,625	2,166 Added 111.25%	4,113 $1.29 Million
Q1 2024 Apr 15, 2024	SELL	$268.87 - $324.56 $38,717 - $46,736	-144 Reduced 6.89%	1,947 $553,000
Q4 2023 Jan 23, 2024	BUY	$255.7 - $288.46 $31,451 - $35,480	123 Added 6.25%	2,091 $602,000
Q3 2023 Oct 17, 2023	SELL	$218.65 - $271.46 $93,582 - $116,184	-428 Reduced 17.86%	1,968 $528,000
Q2 2023 Jul 21, 2023	SELL	$214.27 - $253.37 $389,542 - $460,626	-1,818 Reduced 43.14%	2,396 $531,000
Q1 2023 Apr 24, 2023	BUY	$225.79 - $275.2 $329,653 - $401,792	1,460 Added 53.01%	4,214 $1.02 Million
Q4 2022 Jan 12, 2023	SELL	$229.03 - $291.01 $302,777 - $384,715	-1,322 Reduced 32.43%	2,754 $723,000
Q3 2022 Oct 18, 2022	BUY	$224.46 - $253.15 $33,669 - $37,972	150 Added 3.82%	4,076 $919,000
Q2 2022 Jul 25, 2022	BUY	$230.71 - $256.74 $71,750 - $79,846	311 Added 8.6%	3,926 $955,000
Q1 2022 May 02, 2022	BUY	$219.27 - $242.57 $414,858 - $458,942	1,892 Added 109.81%	3,615 $874,000
Q4 2021 Feb 07, 2022	BUY	$198.88 - $227.6 $95,462 - $109,248	480 Added 38.62%	1,723 $388,000
Q3 2021 Nov 02, 2021	BUY	$212.27 - $248.7 $39,269 - $46,009	185 Added 17.49%	1,243 $264,000
Q2 2021 Aug 02, 2021	SELL	$233.58 - $259.14 $4,905 - $5,441	-21 Reduced 1.95%	1,058 $258,000
Q1 2021 May 10, 2021	BUY	$221.91 - $258.6 $33,064 - $38,531	149 Added 16.02%	1,079 $268,000
Q4 2020 Feb 03, 2021	BUY	$216.38 - $257.67 $6,707 - $7,987	31 Added 3.45%	930 $214,000
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $210,950 - $234,594	899 New	899 $228,000
Q1 2020 May 06, 2020	SELL	$182.24 - $241.7 $177,319 - $235,174	-973 Closed	0 $0
Q4 2019 Jan 28, 2020	BUY	$189.21 - $243.2 $184,101 - $236,633	973 New	973 $235,000
Q1 2019 May 08, 2019	SELL	$180.87 - $203.88 $504,627 - $568,825	-2,790 Closed	0 $0
Q4 2018 Feb 19, 2019	BUY	$178.4 - $208.25 $497,736 - $581,017	2,790 New	2,790 $543,000

Others Institutions Holding AMGN

# of Institutions

3,057

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.3M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Corundum Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Corundum Group, Inc. with notifications on news.

Account

Corundum Group, Inc. Amgen Inc Transaction History